Celltrion Decides to Absorb and Merge with Celltrion Healthcare

Celltrion announced on the 17th that it has decided to merge with Celltrion Healthcare through an absorption-type merger.

The surviving company is Celltrion, and the dissolved company is Celltrion Healthcare, with a merger ratio of 1 to 0.4492620. The merger agreement date is August 17. After the shareholder record date on the 1st of next month, the company will accept notices of objection to the merger from the 25th of the same month until October 20, and hold a shareholders' meeting on October 23.

Celltrion explained, "This is to grow into a true global big pharma by integrating assets for large-scale investment, strengthening cost competitiveness and product differentiation through the integration of development, production, and sales functions, and enhancing transparency and investor trust through simplification of transaction structures, thereby advancing beyond biosimilars to new drugs."

This content was produced with the assistance of AI translation services.